Kisqali (ribociclib) - Novartis
Ribociclib-Induced Vitiligo: A Case Report with Histological, Dermatoscopic, Confocal Microscopy, and LC-OCT Findings Along with a Narrative Literature Review. (PubMed, Dermatol Pract Concept) - Oct 11, 2026 - "The observed alterations in melanocyte regression could represent evidence of systemic immune activation and autoimmunity influencing melanocyte viability. These mechanisms may have significant implications for improving patient prognosis." 
Journal • Review • Dermatology • Immunology • Vitiligo • ER • HER-2
http://www.ncbi.nlm.nih.gov/pubmed/42858444
 
Adele Artemi; Alessia Paganelli; Andrea Ascione; Antonella Chiavassa; Camilla Capasso; Flavia Persechino; Giovanni Pellacani; Silvia Mezi; Simone Amato
 
Oct 11, 2026
 
Prev Next